4.8 Article

Characterization of the thymic IL-7 niche in vivo

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0809559106

关键词

aging; development; thymic epithelial cells; thymus; cytokine

资金

  1. Institut Pasteur
  2. INSERM
  3. Ligue Nationale Contre le Cancer (Equipe Labellisee)
  4. European Molecular Biology Organization

向作者/读者索取更多资源

The thymus represents the cradle for T cell development, with thymic stroma providing multiple soluble and membrane cues to developing thymocytes. Although IL-7 is recognized as an essential factor for thymopoiesis, the environmental niche of thymic IL-7 activity remains poorly characterized in vivo. Using bacterial artificial chromosome transgenic mice in which YFP is under control of IL-7 promoter, we identify a subset of thymic epithelial cells (TECs) that co-express YFP and high levels of Il7 transcripts (IL-7(hi) cells). IL-7(hi) TECs arise during early fetal development, persist throughout life, and co-express homeostatic chemokines (Ccl19, Ccl25, Cxcl12) and cytokines (Il15) that are critical for normal thymopoiesis. In the adult thymus, IL-7(hi) cells localize to the cortico-medullary junction and display traits of both cortical and medullary TECs. Interestingly, the frequency of IL-7(hi) cells decreases with age, suggesting a mechanism for the age-related thymic involution that is associated with declining IL-7 levels. Our temporal-spatial analysis of IL-7-producing cells in the thymus in vivo suggests that thymic IL-7 levels are dynamically regulated under distinct physiological conditions. This IL-7 reporter mouse provides a valuable tool to further dissect the mechanisms that govern thymic IL-7 expression in vivo.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein

Marion Gransagne, Gabriel Ayme, Sebastien Brier, Gaelle Chauveau-Le Friec, Veronique Meriaux, Mireille Nowakowski, Francois Dejardin, Sylvain Levallois, Guilherme Dias de Melo, Flora Donati, Matthieu Prot, Sebastien Brule, Bertrand Raynal, Jacques Bellalou, Pedro Goncalves, Xavier Montagutelli, James P. Di Santo, Francoise Lazarini, Patrick England, Stephane Petres, Nicolas Escriou, Pierre Lafaye

Summary: This study developed a sandwich immunoassay to specifically detect the nucleoprotein (N) of SARS-CoV-2. Seven antibodies were identified that recognized the full N protein and did not cross react with nucleoproteins from common human coronaviruses. The antibodies mainly targeted conformational epitopes in the C-terminal or N-terminal domains and were able to detect SARS-CoV-2 variants.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Immunology

CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages

Elza Evren, Emma Ringqvist, Jean-Marc Doisne, Anna Thaller, Natalie Sleiers, Richard A. Flavell, James P. Di Santo, Tim Willinger

Summary: Evren et al. identify CD116(+) fetal liver cells as precursors of human alveolar macrophages in early life and reveal the impact of cell origin on lung macrophage identity and function.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Cell Biology

LAMP2 regulates autophagy in the thymic epithelium and thymic stroma-dependent CD4 T cell development

Pedro M. Rodrigues, Laura G. Sousa, Chiara Perrod, Ana R. Maceiras, Pedro Ferreirinha, Rita Pombinho, Gema Romera-Cardenas, Maria Gomez-Lazaro, Meryem Senkara, Jelena Pistolic, Didier Cabanes, Ludger Klein, Paul Saftig, Nuno L. Alves

Summary: Thymic epithelial cells (TECs) are crucial for T cell development. This study reveals that lysosomal-associated membrane protein 2 (LAMP2) is highly expressed in cortical TECs (cTECs) and plays a role in autophagy and lysosomal processes. Genetic inactivation of Lamp2 in cTECs impairs the development of CD4 T cells without directing MHC II-restricted cells into the CD8 lineage. The findings suggest that LAMP2 is important for the generation of selecting self-peptides:MHC II complexes in cTECs.

AUTOPHAGY (2023)

Article Developmental Biology

Identification of fibroblast progenitors in the developing mouse thymus

Pedro Ferreirinha, Ruben G. R. Pinheiro, Jonathan J. M. Landry, Nuno L. Alves

Summary: This study identified two distinct subsets of thymic fibroblasts, CD140 alpha beta(+)GP38(+)SCA-1(-) and CD140 alpha beta(+)GP38(+)SCA-1(+), with different developmental features. CD140 alpha beta(+)GP38(+)SCA-1(-) was identified as a source of fibroblast progenitors, while CD140 alpha beta(+)GP38(+)SCA-1(+) represented a mature subset. Furthermore, the study found that thymic crosstalk is crucial for fibroblast maturation.

DEVELOPMENT (2022)

Article Multidisciplinary Sciences

Trained ILC3 responses promote intestinal defense

Nicolas Serafini, Angelique Jarade, Laura Surace, Pedro Goncalves, Odile Sismeiro, Hugo Varet, Rachel Legendre, Jean-Yves Coppee, Olivier Disson, Scott K. Durum, Gad Frankel, James P. Di Santo

Summary: Group 3 innate lymphoid cells (ILC3s) in the intestine remain activated for months after exposure to Citrobacter rodentium, leading to enhanced immune response and defense capability. These trained ILC3s undergo metabolic changes and exhibit enhanced proliferative capacity and IL-22 production.

SCIENCE (2022)

Article Oncology

Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in Cold Melanoma

Saketh S. Dinavahi, Yu-Chi Chen, Kishore Punnath, Arthur Berg, Meenhard Herlyn, Momeneh Foroutan, Nicholas D. Huntington, Gavin P. Robertson

Summary: The targeting of the AKT/WEE1 pathways to induce p53 activation is a novel and effective approach to inhibit tumor development. This study shows that this approach can enhance tumor immunogenicity, induce immunogenic cell death, and recruit immune cells in the tumor microenvironment, resulting in tumor regression.

CANCER IMMUNOLOGY RESEARCH (2022)

Article Oncology

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

Pierre-Louis Bernard, Rebecca Delconte, Sonia Pastor, Vladimir Laletin, Cathy Costa Da Silva, Armelle Goubard, Emmanuelle Josselin, Remy Castellano, Adrien Krug, Julien Vernerey, Raynier Devillier, Daniel Olive, Els Verhoeyen, Eric Vivier, Nicholas D. Huntington, Jacques Nunes, Geoffrey Guittard

Summary: This study investigates the impact of targeting an inhibiting protein called CISH in natural killer (NK) cells on their functions and antitumor properties. The results show that CISH deletion enhances NK cell activation and killing abilities, while limiting NK cell exhaustion. Furthermore, CISH deletion optimizes NK cell accumulation in tumors and improves the effectiveness of antitumor responses. Therefore, CISH has been validated as a potential therapeutic target to enhance NK cell immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Review Hematology

Local and systemic features of ILC immunometabolism

Laura Surace, James P. Di Santo

Summary: This review discusses the role of innate lymphoid cells (ILCs) as metabolic sentinels and how specific activities of ILC subsets influence homeostasis and disease. Recent studies have found that ILCs' metabolism, phenotype, and function are shaped by signals from the tissue microenvironment. ILCs have emerged as crucial sensors of metabolic stress.

CURRENT OPINION IN HEMATOLOGY (2022)

Article Multidisciplinary Sciences

Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy

Ashleigh R. Poh, Christopher G. Love, David Chisanga, James H. Steer, David Baloyan, Michael Chopin, Stephen Nutt, Jai Rautela, Nicholas D. Huntington, Nima Etemadi, Megan O'Brien, Ryan O'Keefe, Lesley G. Ellies, Christophe Macri, Justine D. Mintern, Lachlan Whitehead, Gangadhara Gangadhara, Louis Boon, Ashwini L. Chand, Clifford A. Lowell, Wei Shi, Fiona J. Pixley, Matthias Ernst

Summary: Genetic ablation or therapeutic inhibition of the myeloid-specific hematopoietic cell kinase (HCK) enhances the response to immunotherapy by modifying the tumor microenvironment and promoting immune cell activation.

SCIENCE ADVANCES (2022)

Review Immunology

T-cell selection in the thymus: New routes toward the identification of the self-peptide ligandome presented by thymic epithelial cells

Laura G. G. Sousa, Pedro M. M. Rodrigues, Nuno L. L. Alves

Summary: Within the thymus, thymic epithelial cells play a crucial role in the selection of functional T cells expressing a diverse and self-tolerant T-cell receptor repertoire. This review summarizes recent studies on the composition of cortical and medullary TEC microenvironments and discusses the molecular processes controlling TEC function in T-cell selection, particularly the role of cortical TECs in positive selection and the generation of self-peptides:MHC II complexes.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Cell Biology

CD45 limits early Natural Killer cell development

Lizeth G. Meza Guzman, Craig D. Hyland, Grace M. Bidgood, Evelyn Leong, Zihan Shen, Wilford Goh, Jai Rautela, James E. Vince, Sandra E. Nicholson, Nicholas D. Huntington

Summary: The clinical development of NK cell-mediated immunotherapy is a significant milestone in cancer treatment, but improving NK cell persistence and overcoming tumor microenvironment suppression are challenges. This study explores the role of CD45 in NK cell homeostasis and shows that CD45 deficiency does not enhance NK cell persistence, but instead results in a developmental defect. Inhibiting CD45 in progenitor or stem cell populations may improve the yield of in vitro generated NK cells for adoptive therapy.

IMMUNOLOGY AND CELL BIOLOGY (2023)

Article Immunology

Ironman training for NK cells

Nicholas D. Huntington

Summary: IRF4 is necessary for the differentiation of T cells, B cells, and some myeloid cells. A recent study reveals that IRF4 is upregulated after natural killer (NK) cell activation and is essential for the differentiation and expansion of virus-specific NK cells by regulating nutrient acquisition, including iron uptake.

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity

Shuwei Liang, Eric Tran, Xin Du, Jiajun Dong, Harrison Sudholz, Hao Chen, Zihan Qu, Nicholas D. Huntington, Jeffrey J. Babon, Nadia J. Kershaw, Zhong-Yin Zhang, Jonathan B. Baell, Florian Wiede, Tony Tiganis

Summary: In this study, the authors demonstrate that inhibition of PTP1B and PTPN2 in tumor cells and T cells with a small molecule inhibitor represses the growth of immunogenic and cold tumors, and enhances response to anti-PD-1 immunotherapy without promoting immune-related toxicities.

NATURE COMMUNICATIONS (2023)

Article Immunology

CIS controls the functional polarization of GM-CSF-derived macrophages

Shengbo Zhang, Jai Rautela, Naiara G. Bediaga, Tatiana B. Kolesnik, Yue You, Junli Nie, Laura F. Dagley, Justin Bedo, Hanqing Wang, Li Sun, Robyn Sutherland, Elliot Surgenor, Nadia Iannarella, Rhys Allan, Fernando Souza-Fonseca-Guimaraes, Yi Xie, Qike Wang, Yuxia Zhang, Yuekang Xu, Stephen L. Nutt, Andrew M. Lew, Nicholas D. Huntington, Sandra E. Nicholson, Michael Chopin, Yifan Zhan

Summary: The cytokine GM-CSF can differentiate monocytes into macrophages with opposing functions, proinflammatory M1-like and immunosuppressive M2-like. In this study, it was found that the protein CIS plays a critical role in the GM-CSF signaling pathway, and deficiency of CIS leads to the differentiation of monocytes into immunosuppressive M2-like macrophages, promoting allergic inflammation.

CELLULAR & MOLECULAR IMMUNOLOGY (2023)

Article Oncology

TGFb and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity

Fernando Souza-Fonseca-Guimaraes, Gustavo R. Rossi, Laura F. Dagley, Momeneh Foroutan, Timothy R. McCulloch, Jumana Yousef, Hae-Young Park, Jennifer H. Gunter, Paul A. Beavis, Cheng-Yu Lin, Soroor Hediyeh-Zadeh, Tania Camilleri, Melissa J. Davis, Nicholas D. Huntington

CANCER IMMUNOLOGY RESEARCH (2022)

暂无数据